New Jersey Health Center COVID-19 Survey Summary Report

Latest data from January 14, 2022

Number of Health Center respondents = 16 (67% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 27,360
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) 70.56%
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 7,386
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) 72.58%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, Antigen)2 Patients Tested Positive, Virus Detection (PCR, Antigen)2
White, Non-Hispanic/Latino Patients 24.15% 22.39%
White, Hispanic/Latino Patients 31.85% 33.71%
Black/African American, Non-Hispanic/Latino Patients 9.16% 10.38%
Black/African American, Hispanic/Latino Patients 2.56% 3.36%
Asian Patients3 1.58% 1.29%
American Indian/Alaska Native Patients3 3.56% 2.65%
Native Hawaiian/Other Pacific Islander Patients3 1.59% 1.18%
Patients with More Than One Race3 4.35% 2.59%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 3.24% 4.12%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 4.77% 6.11%
Unreported/Refused to Report Race and Ethnicity 13.19% 12.23%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 2,433
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 85.89%
COVID-19 Immunization Series Completed 1,877
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 83.55%
COVID-19 Immunization Series Additional 6,210
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 83.16%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 12.04% 14.33% 14.40%
White, Hispanic/Latino Patients 41.84% 36.12% 39.57%
Black/African American, Non-Hispanic/Latino Patients 12.74% 15.50% 10.43%
Black/African American, Hispanic/Latino Patients 2.30% 1.44% 1.18%
Asian Patients3 1.32% 4.95% 2.98%
American Indian/Alaska Native Patients3 2.10% 1.76% 5.52%
Native Hawaiian/Other Pacific Islander Patients3 0.45% 0.59% 0.47%
Patients with More Than One Race3 5.34% 5.70% 4.88%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 7.23% 6.71% 6.09%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 3.12% 3.30% 2.05%
Unreported/Refused to Report Race and Ethnicity 11.51% 9.59% 12.45%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)

Metrics Value
Less Than 1 Hour 6.25%
1 to 24 Hours 18.75%
More Than 24 Hours 75.00%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 12.50%
Staffing to administer the vaccine 56.25%
Vaccine confidence 37.50%
Vaccine storage capacity 0.00%
Vaccine supply 0.00%
Other 6.25%
None 18.75%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 12.50%
Average Percent of Health Center Visits Conducted Virtually 24.06%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 56.25%
Number of Mobile Van Sites 1
Number of Pop-up Clinics 60
Number of School-Based Vaccination Sites 3
Number of Family Vaccination Clinics 35

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 6.25%
Refer patients to another organization that provides monoclonal antibody therapies 37.50%
None 56.25%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 18.75%
Patient awareness/education 12.50%
Staffing capacity 18.75%
Therapy administration/onsite logistics 25.00%
Other 6.25%
None 43.75%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 2
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 3,593

Test Kit Distribution Methods4

Metrics Value
Provide to Existing Health Center Patients 100.00%
Provide to General Public Who Came to the Health Center 50.00%
Provide at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 50.00%
Provide at Other Community Events 0.00%
Provide through direct outreach to specific populations (i.e., individuals experiencing homelessness, MSAWs, residents of public housing, individuals with limited English proficiency) 50.00%
Other 50.00%

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 1
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication5 33.33%

Oral Antiviral Medication Distribution by Race and Ethnicity5

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients 66.67%
White, Hispanic/Latino Patients 33.33%
Black/African American, Non-Hispanic/Latino Patients 0.00%
Black/African American, Hispanic/Latino Patients 0.00%
Asian Patients3 0.00%
American Indian/Alaska Native Patients3 0.00%
Native Hawaiian/Other Pacific Islander Patients3 0.00%
Patients with More Than One Race3 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.00%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.00%
Unreported/Refused to Report Race and Ethnicity 0.00%

Oral Antiviral Medication Distribution by Special/Vulnerable Population5

Metrics Value
Migratory/Agricultural Workers 0.00%
Patients Experiencing Homelessness 0.00%
Patients Who Are Residents of Public Housing 33.33%
Patients with Limited English Proficiency 33.33%
Children Under 18 Years of Age 0.00%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed courses of COVID-19 oral antiviral medication received through the HRSA Health Center COVID-19 Therapeutics Program as the denominator.

Date Last Reviewed:  January 2022